Therapy-related Acute Myelogenous Leukemia and Myelodysplastic Syndrome in Patients With Acute Lymphoblastic Leukemia Treated With the Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Regimens

Ítems similars

• Results of the Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Regimen in Elderly Patients With Acute Lymphocytic Leukemia
  per: O’Brien, Susan, et al.
  Publicat: (2008)
• Adults With Acute Lymphoblastic Leukemia and Translocation (1;19) Abnormality Have a Favorable Outcome With Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Alternating With Methotrexate and High-Dose Cytarabine Chemotherapy
  per: Garg, Ravin, et al.
  Publicat: (2009)
• Anthracycline Dose Intensification in Adult Acute Lymphoblastic Leukemia: Lack of Benefit in the Context of the Fractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Regimen
  per: Thomas, Deborah, et al.
  Publicat: (2010)
• Predictors and Outcome of Acute Kidney Injury in Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplastic Syndrome
  per: Lahoti, Amit, et al.
  Publicat: (2010)
• Report of a phase 1/2 study of a combination of azacitidine and cytarabine in acute myelogenous leukemia and high-risk myelodysplastic syndromes
  per: BORTHAKUR, GAUTAM, et al.
  Publicat: (2010)